FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021862174> ?p ?o ?g. }

• W3021862174 abstract "Malnutrition is common in patients with chronic kidney disease (CKD) on dialysis. Oral protein-based nutritional supplements are often provided to patients whose oral intake is otherwise insufficient to meet their energy and protein needs. Evidence for the effectiveness of oral protein-based nutritional supplements in this population is limited.The aims of this review were to determine the benefits and harms of using oral protein-based nutritional supplements to improve the nutritional state of patients with CKD requiring dialysis.We searched the Cochrane Kidney and Transplant Register of Studies up to 12 December 2019 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.Randomised controlled trials (RCTs) of patients with CKD requiring dialysis that compared oral protein-based nutritional supplements to no oral protein-based nutritional supplements or placebo.Two authors independently assessed studies for eligibility, risk of bias, and extracted data from individual studies. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios and their 95% confidence intervals (CI) for dichotomous outcomes, and mean difference and 95% CI for continuous outcomes.Twenty-two studies (1278 participants) were included in this review. All participants were adults on maintenance dialysis of whom 79% were on haemodialysis (HD) and 21% peritoneal dialysis. The follow-up period ranged from one to 12 months. The majority of studies were at unclear risk of selection, performance, and reporting bias. The detection bias was high for self-reported outcomes. Oral protein-based nutritional supplements probably lead to a higher mean change in serum albumin compared to the control group (16 studies, 790 participants: MD 0.19 g/dL, 95% CI 0.05 to 0.33; moderate certainty evidence), although there was considerable heterogeneity in the combined analysis (I2 = 84%). The increase was more evident in HD participants (10 studies, 526 participants: MD 0.28 g/dL, 95% CI 0.11 to 0.46; P = 0.001 for overall effect) and malnourished participants (8 studies, 405 participants: MD 0.31 g/dL, 95% CI 0.10 to 0.52, P = 0.003 for overall effect). Oral protein-based nutritional supplements also probably leads to a higher mean serum albumin at the end of the intervention (14 studies, 715 participants: MD 0.14 g/dL, 95% CI 0 to 0.27; moderate certainty evidence), however heterogeneity was again high (I2 = 80%). Again the increase was more evident in HD participants (9 studies, 498 participants: MD 0.21 g/dL, 95% CI 0.03 to 0.38; P = 0.02 for overall effect) and malnourished participants (7 studies, 377 participants: MD 0.25 g/dL, 95% CI 0.02 to 0.47; P = 0.03 for overall effect). Compared to placebo or no supplement, low certainty evidence showed oral protein-based nutritional supplements may result in a higher serum prealbumin (4 studies, 225 participants: MD 2.81 mg/dL, 95% CI 2.19 to 3.43), and mid-arm muscle circumference (4 studies, 216 participants: MD 1.33 cm, 95% CI 0.24 to 2.43) at the end of the intervention. Compared to placebo or no supplement, oral protein-based nutritional supplements may make little or no difference to weight (8 studies, 365 participants: MD 2.83 kg, 95% CI -0.43 to 6.09; low certainty evidence), body mass index (9 studies, 368 participants: MD -0.04 kg/m2, 95% CI -0.74 to 0.66; moderate certainty evidence) and lean mass (5 studies, 189 participants: MD 1.27 kg, 95% CI -1.61 to 4.51; low certainty evidence). Due to very low quality of evidence, it is uncertain whether oral protein-based nutritional supplements affect triceps skinfold thickness, mid-arm circumference, C-reactive protein, Interleukin 6, serum potassium, or serum phosphate. There may be little or no difference in the risk of developing gastrointestinal intolerance between participants who received oral protein-based nutritional supplements compared with placebo or no supplement (6 studies, 426 participants: RR 2.81, 95% CI 0.58 to 13.65, low certainty evidence). It was not possible to draw conclusions about cost or quality of life, and deaths were not reported as a study outcome in any of the included studies.Overall, it is likely that oral protein-based nutritional supplements increase both mean change in serum albumin and serum albumin at end of intervention and may improve serum prealbumin and mid-arm muscle circumference. The improvement in serum albumin was more evident in haemodialysis and malnourished participants. However, it remains uncertain whether these results translate to improvement in nutritional status and clinically relevant outcomes such as death. Large well-designed RCTs in this population are required." @default.
• W3021862174 created "2020-05-13" @default.
• W3021862174 creator A5027273589 @default.
• W3021862174 creator A5027729728 @default.
• W3021862174 creator A5039182249 @default.
• W3021862174 creator A5048650617 @default.
• W3021862174 creator A5082456091 @default.
• W3021862174 creator A5083932963 @default.
• W3021862174 creator A5076554319 @default.
• W3021862174 date "2020-05-11" @default.
• W3021862174 modified "2023-10-10" @default.
• W3021862174 title "Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis" @default.
• W3021862174 cites W1005726334 @default.
• W3021862174 cites W1706399446 @default.
• W3021862174 cites W1798045141 @default.
• W3021862174 cites W1902719690 @default.
• W3021862174 cites W1955606617 @default.
• W3021862174 cites W1965049217 @default.
• W3021862174 cites W1966457702 @default.
• W3021862174 cites W1968935282 @default.
• W3021862174 cites W1975977638 @default.
• W3021862174 cites W1981553394 @default.
• W3021862174 cites W1986772336 @default.
• W3021862174 cites W2011769683 @default.
• W3021862174 cites W2012700455 @default.
• W3021862174 cites W2016489160 @default.
• W3021862174 cites W2028424800 @default.
• W3021862174 cites W2030940155 @default.
• W3021862174 cites W2033077875 @default.
• W3021862174 cites W2041520440 @default.
• W3021862174 cites W2041637013 @default.
• W3021862174 cites W2041884196 @default.
• W3021862174 cites W2043050859 @default.
• W3021862174 cites W2045927917 @default.
• W3021862174 cites W2046648011 @default.
• W3021862174 cites W2049510456 @default.
• W3021862174 cites W2051865146 @default.
• W3021862174 cites W2054774517 @default.
• W3021862174 cites W2055473141 @default.
• W3021862174 cites W2063801972 @default.
• W3021862174 cites W2072519920 @default.
• W3021862174 cites W2076478043 @default.
• W3021862174 cites W2081385953 @default.
• W3021862174 cites W2091735632 @default.
• W3021862174 cites W2096354269 @default.
• W3021862174 cites W2097830819 @default.
• W3021862174 cites W2103196030 @default.
• W3021862174 cites W2104675861 @default.
• W3021862174 cites W2107957405 @default.
• W3021862174 cites W2125435699 @default.
• W3021862174 cites W2126649629 @default.
• W3021862174 cites W2130356461 @default.
• W3021862174 cites W2133169646 @default.
• W3021862174 cites W2136711097 @default.
• W3021862174 cites W2137098613 @default.
• W3021862174 cites W2137421196 @default.
• W3021862174 cites W2141297458 @default.
• W3021862174 cites W2141821614 @default.
• W3021862174 cites W2145214144 @default.
• W3021862174 cites W2146444987 @default.
• W3021862174 cites W2149262429 @default.
• W3021862174 cites W2149324004 @default.
• W3021862174 cites W2150153646 @default.
• W3021862174 cites W2157412872 @default.
• W3021862174 cites W2165010366 @default.
• W3021862174 cites W2166198702 @default.
• W3021862174 cites W2169003962 @default.
• W3021862174 cites W2183846267 @default.
• W3021862174 cites W2220132135 @default.
• W3021862174 cites W2274618407 @default.
• W3021862174 cites W2331632797 @default.
• W3021862174 cites W2337627193 @default.
• W3021862174 cites W2406188630 @default.
• W3021862174 cites W2409300629 @default.
• W3021862174 cites W2430595324 @default.
• W3021862174 cites W2437444137 @default.
• W3021862174 cites W2472910166 @default.
• W3021862174 cites W2480660436 @default.
• W3021862174 cites W2503466906 @default.
• W3021862174 cites W2510584645 @default.
• W3021862174 cites W2588681363 @default.
• W3021862174 cites W2597625473 @default.
• W3021862174 cites W2737192790 @default.
• W3021862174 cites W2769936423 @default.
• W3021862174 cites W2774870903 @default.
• W3021862174 cites W2803838096 @default.
• W3021862174 cites W2889567170 @default.
• W3021862174 cites W2916841405 @default.
• W3021862174 cites W2926651991 @default.
• W3021862174 cites W2946832460 @default.
• W3021862174 cites W2981076020 @default.
• W3021862174 cites W3021862174 @default.
• W3021862174 cites W4241269166 @default.
• W3021862174 cites W4247429830 @default.
• W3021862174 cites W4253331889 @default.
• W3021862174 cites W4294232908 @default.
• W3021862174 doi "https://doi.org/10.1002/14651858.cd012616.pub2" @default.
• W3021862174 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7212094" @default.
• W3021862174 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32390133" @default.
• W3021862174 hasPublicationYear "2020" @default.

• next